Xeno Transplants Corporation (XENO)

0.0001 0.0000 (0.00%) At close: 01:55PM EDT

Xeno Transplants Corporation

143 Gardner Road
Brookline, MA 02445
United States
617-566-5228

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Wayne Smith	Chief Financial Officer, Secretary, Treasurer and Director	20.96k	N/A	1957
Dr. Elliot Lebowitz Ph.D.	Chief Executive Officer, President and Director	N/A	N/A	1942

Amounts are as of December 31, 2007 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Xeno Transplants Corporation operates as a bio-technology research and development company. The company, through a license agreement with Massachusetts General Hospital, intends to develop, manufacture, distribute, and use products and processes for public use with regard to xenotransplantation. The Xenotransplantation is intended to address the problems arising from the limited supply of available human cells, tissues, and organs for transplantation by developing technologies to permit the transplantation of cells, tissues, and organs from other species into humans, such as swine. Xeno Transplants Corporation was incorporated in 2004 and is based in Brookline, Massachusetts.

Corporate Governance

Xeno Transplants Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.